186 related articles for article (PubMed ID: 24951468)
1. Health-related quality of life in children with newly diagnosed immune thrombocytopenia.
Heitink-Pollé KM; Haverman L; Annink KV; Schep SJ; de Haas M; Bruin MC
Haematologica; 2014 Sep; 99(9):1525-31. PubMed ID: 24951468
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in children with chronic immune thrombocytopenia in China.
Zhang H; Wang L; Quan M; Huang J; Wu P; Lu Q; Fang Y
Health Qual Life Outcomes; 2016 Mar; 14():45. PubMed ID: 26979950
[TBL] [Abstract][Full Text] [Related]
3. Analysis of health-related quality of life in children with immune thrombocytopenia and their parents using the kids' ITP tools.
Zilber R; Bortz AP; Yacobovich J; Yaniv I; Tamary H
J Pediatr Hematol Oncol; 2012 Jan; 34(1):2-5. PubMed ID: 22215093
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life of Egyptian children with immune thrombocytopenia and their parents.
Mokhtar GM; Farid SM; Shaker NM; Farrag KE
J Pediatr Hematol Oncol; 2014 Apr; 36(3):194-9. PubMed ID: 24322497
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in childhood immune thrombocytopenia: international validation of the kids' ITP tools.
Klaassen RJ; Blanchette V; Burke TA; Wakefield C; Grainger JD; Gaedicke G; Riedlinger A; Dufort G; Citrin E; Reguerre Y; Pellier I; Curtis C; Young NL
Pediatr Blood Cancer; 2013 Jan; 60(1):95-100. PubMed ID: 22848040
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network.
Strullu M; Rakotonjanahary J; Tarral E; Savagner C; Thomas C; Méchinaud F; Reguerre Y; Poignant S; Boutet A; Bassil J; Médinger D; Quemener E; Young NL; Rachieru P; Klaassen RJ; Pellier I
Health Qual Life Outcomes; 2013 Nov; 11():193. PubMed ID: 24225051
[TBL] [Abstract][Full Text] [Related]
7. Patterns and influences in health-related quality of life in children with immune thrombocytopenia: A study from the Dallas ITP Cohort.
Flores A; Klaassen RJ; Buchanan GR; Neunert CE
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111877
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in immune thrombocytopenia following treatment.
Grainger JD; Young NL; Blanchette VS; Klaassen RJ
Arch Dis Child; 2013 Nov; 98(11):895-7. PubMed ID: 23956257
[TBL] [Abstract][Full Text] [Related]
9. A clinical prediction score for transient versus persistent childhood immune thrombocytopenia.
Schmidt DE; Wendtland Edslev P; Heitink-Pollé KMJ; Mertens B; Bruin MCA; Kapur R; Vidarsson G; van der Schoot CE; Porcelijn L; van der Bom JG; Rosthøj S; de Haas M
J Thromb Haemost; 2021 Jan; 19(1):121-130. PubMed ID: 33058474
[TBL] [Abstract][Full Text] [Related]
10. Relationships among bleeding severity, health-related quality of life, and platelet count in children with immune thrombocytopenic purpura.
Neunert CE; Buchanan GR; Blanchette V; Barnard D; Young NL; Curtis C; Klaassen RJ
Pediatr Blood Cancer; 2009 Oct; 53(4):652-4. PubMed ID: 19492316
[TBL] [Abstract][Full Text] [Related]
11. Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia.
Shimano KA; Neunert C; Bussel JB; Klaassen RJ; Bhat R; Pastore YD; Lambert MP; Bennett CM; Despotovic JM; Forbes P; Grace RF
Pediatr Blood Cancer; 2021 Jun; 68(6):e29023. PubMed ID: 33764667
[TBL] [Abstract][Full Text] [Related]
12. Validity, reliability, and responsiveness of a new measure of health-related quality of life in children with immune thrombocytopenic purpura: the Kids' ITP Tools.
Klaassen RJ; Blanchette VS; Barnard D; Wakefield CD; Curtis C; Bradley CS; Neufeld EJ; Buchanan GR; Silva MP; Chan AK; Young NL
J Pediatr; 2007 May; 150(5):510-5, 515.e1. PubMed ID: 17452226
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of the effect of romiplostim on child health-related quality of life (HRQoL) and parental burden in immune thrombocytopenia (ITP).
Klaassen RJ; Mathias SD; Buchanan G; Bussel J; Deuson R; Young NL; Collier A; Bomgaars L; Blanchette V
Pediatr Blood Cancer; 2012 Mar; 58(3):395-8. PubMed ID: 21910213
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in children with chronic immune thrombocytopenia treated with eltrombopag in the PETIT study.
Grainger JD; Blanchette VS; Grotzinger KM; Roy A; Bussel JB
Br J Haematol; 2019 Apr; 185(1):102-106. PubMed ID: 30592022
[TBL] [Abstract][Full Text] [Related]
15. Fatigue in children and adolescents with immune thrombocytopenia.
Grace RF; Klaassen RJ; Shimano KA; Lambert MP; Grimes A; Bussel JB; Breakey VR; Pastore YD; Black V; Overholt K; Bhat R; Forbes PW; Neunert C
Br J Haematol; 2020 Oct; 191(1):98-106. PubMed ID: 32501532
[TBL] [Abstract][Full Text] [Related]
16. Development of disease-specific health-related quality-of-life instruments for children with immune thrombocytopenic purpura and their parents.
Barnard D; Woloski M; Feeny D; McCusker P; Wu J; David M; Bussel J; Lusher J; Wakefield C; Henriques S; Blanchette V;
J Pediatr Hematol Oncol; 2003 Jan; 25(1):56-62. PubMed ID: 12544774
[TBL] [Abstract][Full Text] [Related]
17. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin vs observation in childhood immune thrombocytopenia: a randomized controlled trial.
Heitink-Pollé KMJ; Uiterwaal CSPM; Porcelijn L; Tamminga RYJ; Smiers FJ; van Woerden NL; Wesseling J; Vidarsson G; Laarhoven AG; de Haas M; Bruin MCA;
Blood; 2018 Aug; 132(9):883-891. PubMed ID: 29945954
[TBL] [Abstract][Full Text] [Related]
19. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.
Kime C; Klima J; Rose MJ; O'Brien SH
Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
